Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by 5,000+ Wall Street analysts over the past 3-months

#	Name	Upside %	Analysts bullish %
76	76 AnaptysBio ANAB $770M	114% upside 3 price targets	0
77	77 New Fortress Energy NFE $1.14B	113% upside 3 price targets	0
78	78 Avidity Biosciences RNA $3.79B	113% upside 9 price targets	0
79	79 Viridian Therapeutics VRDN $1.39B	111% upside 5 price targets	0
80	80 CG Oncology CGON $2.04B	111% upside 6 price targets	0
81	81 Celcuity CELC $516M	110% upside 3 price targets	0
82	82 Sutro Biopharma STRO $64.3M	110% upside 3 price targets	0
83	83 IDEAYA Biosciences IDYA $1.97B	108% upside 3 price targets	0
84	84 Weave Communications WEAV $582M	107% upside 3 price targets	0
85	85 Eton Pharmaceutcials ETON $389M	105% upside 3 price targets	0
86	86 Denali Therapeutics DNLI $2.11B	103% upside 4 price targets	0
87	87 Arcus Biosciences RCUS $988M	101% upside 4 price targets	0
88	88 Savara SVRA $413M	99% upside 4 price targets	0
89	89 Celldex Therapeutics CLDX $1.52B	97% upside 5 price targets	0
90	90 Liquidia Corp LQDA $1.2B	97% upside 7 price targets	0
91	91 UroGen Pharma URGN $657M	97% upside 8 price targets	0
92	SEPN 92 Septerna, Inc. Common Stock SEPN $523M	96% upside 3 price targets	0
93	93 BioCryst Pharmaceuticals BCRX $1.83B	95% upside 8 price targets	0
94	94 NewAmsterdam Pharma NAMS $2.42B	95% upside 3 price targets	0
95	95 Travere Therapeutics TVTX $1.46B	94% upside 6 price targets	0
96	96 Cytokinetics CYTK $4.42B	91% upside 9 price targets	0
97	97 AudioEye AEYE $146M	91% upside 3 price targets	0
98	98 Castle Biosciences CSTL $568M	90% upside 3 price targets	0
99	99 Cogent Biosciences COGT $1.25B	87% upside 6 price targets	0
100	100 Viasat VSAT $1.96B	86% upside 3 price targets	0

1 23456

64